The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
The Process of Structure-Based Drug Design
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996) · Journal of Biomolecular NMR · doi:10.1007/bf00228148 · Cited by 5,502
WHAT IF: A molecular modeling and drug design program
Vriend, G. (1990) · Journal of Molecular Graphics · doi:10.1016/0263-7855(90)80070-v · Cited by 3,469
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Goodford, P. J. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00145a002 · Cited by 2,634
Pervushin, K., Riek, R., Wider, G., & Wüthrich, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12366 · Cited by 2,445
Cited by
The role of natural product chemistry in drug discovery
Butler, M. S. (2004) · Journal of Natural Products · doi:10.1021/np040106y · Cited by 1,381
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Krishnamurthy, V. M., Kaufman, G. K., Urbach, A. R., Gitlin, I., Gudiksen, K. L., Weibel, D. B., & Whitesides, G. M. (2008) · Chemical Reviews · doi:10.1021/cr050262p · Cited by 761
Role of computer-aided drug design in modern drug discovery
Macalino, S. J. Y., Gosu, V., Hong, S., & Choi, S. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0640-5 · Cited by 762
A Structure-Based Drug Discovery Paradigm
Batool, M., Ahmad, B., & Choi, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112783 · Cited by 744
Current Challenges and Trends in the Discovery of Agrochemicals
Lamberth, C., Jeanmart, S., Luksch, T., & Plant, A. (2013) · Science · doi:10.1126/science.1237227 · Cited by 643
Computational methods in drug discovery
Leelananda, S. P., & Lindert, S. (2016) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.12.267 · Cited by 639
Sabe, V. T., Ntombela, T., Jhamba, L. A., Maguire, G. E. M., Govender, T., Naicker, T., & Kruger, H. G. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113705 · Cited by 625
In silico methods and tools for drug discovery
Shaker, B., Ahmad, S., Lee, J., Jung, C., & Na, D. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104851 · Cited by 607
Rifaioglu, A. S., Atas, H., Martin, M. J., Cetin-Atalay, R., Atalay, V., & Doğan, T. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bby061 · Cited by 529
Innovative lead discovery strategies for tropical diseases
Nwaka, S., & Hudson, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2144 · Cited by 521
Natural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491
Homology modeling in drug discovery: current trends and applications
Cavasotto, C. N., & Phatak, S. S. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.04.006 · Cited by 483
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
Günther, S., Reinke, P. Y. A., Fernández-García, Y., Lieske, J., Lane, T. J., Ginn, H. M., Koua, F. H. M., Ehrt, C., Ewert, W., Oberthuer, D., et al. (2021) · Science · doi:10.1126/science.abf7945 · Cited by 372
Potential of quantum computing for drug discovery
Cao, Y., Romero, J., & Aspuru-Guzik, A. (2018) · IBM Journal of Research and Development · doi:10.1147/jrd.2018.2888987 · Cited by 357
Structure-based drug design with equivariant diffusion models
Schneuing, A., Harris, C., Du, Y., Didi, K., Jamasb, A., Igashov, I., Du, W., Gomes, C., Blundell, T. L., Lio, P., et al. (2024) · Nature Computational Science · doi:10.1038/s43588-024-00737-x · Cited by 316
Structure-based drug design to augment hit discovery
Kalyaanamoorthy, S., & Chen, Y.-P. P. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.07.006 · Cited by 296
Computational Modeling of β-Secretase 1 (BACE-1) Inhibitors Using Ligand Based Approaches
Subramanian, G., Ramsundar, B., Pande, V., & Denny, R. A. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00290 · Cited by 285
Grinter, S., & Zou, X. (2014) · Molecules · doi:10.3390/molecules190710150 · Cited by 260
Use of machine learning approaches for novel drug discovery
Lima, A. N., Philot, E. A., Trossini, G. H. G., Scott, L. P. B., Maltarollo, V. G., & Honorio, K. M. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1146250 · Cited by 254
eToxPred: a machine learning-based approach to estimate the toxicity of drug candidates
Pu, L., Naderi, M., Liu, T., Wu, H.-C., Mukhopadhyay, S., & Brylinski, M. (2019) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-018-0282-6 · Cited by 212
“Although the combination of pharmacophore modeling, QSAR, and VS techniques has been demonstrated to be valuable in the absence of the protein structure data [12, 13], the three-dimensional (3D) information on the target protein allows employing structure-based drug design (SBDD) [14] in CADD.”
MethodStructure-based drug design with geometric deep learning
Isert, C., Atz, K., & Schneider, G. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102548 · Cited by 182
The Advent of Generative Chemistry
Vanhaelen, Q., Lin, Y.-C., & Zhavoronkov, A. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00088 · Cited by 151
AI-Based Protein Structure Prediction in Drug Discovery: Impacts and Challenges
Schauperl, M., & Denny, R. A. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00026 · Cited by 122
3D molecular generative framework for interaction-guided drug design
(2024) · doi:10.1038/s41467-024-47011-2 · Cited by 88
Douglass, E. F., Allaway, R. J., Szalai, B., Wang, W., Tian, T., Fernández-Torras, A., Realubit, R., Karan, C., Zheng, S., Pessia, A., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100492 · Cited by 68
Protein‐protein interactions as antibiotic targets: A medicinal chemistry perspective
Cossar, P. J., Lewis, P. J., & McCluskey, A. (2020) · Medicinal Research Reviews · doi:10.1002/med.21519 · Cited by 55
Grover, A., Katiyar, S. P., Jeyakanthan, J., Dubey, V. K., & Sundar, D. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-s7-s20 · Cited by 52
A new paradigm for applying deep learning to protein–ligand interaction prediction
Wang, Z., Wang, S., Li, Y., Guo, J., Wei, Y., Mu, Y., Zheng, L., & Li, W. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae145 · Cited by 41
Race to the Bottom: Competition and Quality in Science
Hill, R., & Stein, C. (2025) · The Quarterly Journal of Economics · doi:10.1093/qje/qjaf010 · Cited by 40
A deep learning-based method for the prediction of DNA interacting residues in a protein
Patiyal, S., Dhall, A., & Raghava, G. P. S. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac322 · Cited by 38
Quantitatively accounting for protein reorganization in computer-aided drug design
Fajer, M., Borrelli, K., Abel, R., & Wang, L. (2023) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.3c00009 · Cited by 18
How accurately can one predict drug binding modes using AlphaFold models?
Karelina, M., Noh, J. J., & Dror, R. O. (2023) · doi:10.7554/elife.89386.1 · Cited by 16
(2025) · doi:10.1371/journal.pcbi.1013216 · Cited by 4
Connecting the dots: deep learning-based automated model building methods in cryo-EM
Bansia, H., & des Georges, A. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1613399 · Cited by 2
Influence of contact map topology on RNA structure prediction
Faber, C., Upadhyay, U., Taubert, O., & Schug, A. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1370 · Cited by 1
Metadata
- Authors
- Anderson, A. C.
- Venue
- Chemistry & Biology
- Publisher
- Elsevier BV
- Published
- 2003-09
- Volume
- 10
- Issue
- 9
- Pages
- 787-797
- ISSN
- 1074-5521 (ISSN-L)
- OpenAlex
- W1975447903
- Cited by
- 939
- References
- 81
- FWCI
- 9.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.